| Product Code: ETC13117647 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The import shipments of pneumococcal vaccines to Niger in 2024 have been dominated by China, France, India, Benin, and Ghana. Despite a decrease in the growth rate from 2023 to 2024, the cumulative annual growth rate (CAGR) for the period 2020-2024 stands impressively high at 26.19%. The Herfindahl-Hirschman Index (HHI) indicates a significant level of concentration in the market, which has slightly decreased from very high in 2023 to high in 2024. This data suggests a competitive landscape with potential opportunities for market expansion and diversification in the coming years.


1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Niger Pneumococcal Vaccines Market Overview |
3.1 Niger Country Macro Economic Indicators |
3.2 Niger Pneumococcal Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Niger Pneumococcal Vaccines Market - Industry Life Cycle |
3.4 Niger Pneumococcal Vaccines Market - Porter's Five Forces |
3.5 Niger Pneumococcal Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Niger Pneumococcal Vaccines Market Revenues & Volume Share, By Vaccine Technology, 2021 & 2031F |
3.7 Niger Pneumococcal Vaccines Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Niger Pneumococcal Vaccines Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Niger Pneumococcal Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination and preventive healthcare in Niger |
4.2.2 Government initiatives and funding to improve immunization programs |
4.2.3 Rising incidence of pneumococcal diseases in Niger |
4.3 Market Restraints |
4.3.1 Limited healthcare infrastructure and resources in remote areas of Niger |
4.3.2 High cost associated with pneumococcal vaccines |
4.3.3 Challenges in vaccine distribution and storage in regions with poor infrastructure |
5 Niger Pneumococcal Vaccines Market Trends |
6 Niger Pneumococcal Vaccines Market, By Types |
6.1 Niger Pneumococcal Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Niger Pneumococcal Vaccines Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Niger Pneumococcal Vaccines Market Revenues & Volume, By Conjugate, 2021 - 2031F |
6.1.4 Niger Pneumococcal Vaccines Market Revenues & Volume, By Polysaccharide, 2021 - 2031F |
6.1.5 Niger Pneumococcal Vaccines Market Revenues & Volume, By Combination, 2021 - 2031F |
6.1.6 Niger Pneumococcal Vaccines Market Revenues & Volume, By Live Attenuated, 2021 - 2031F |
6.1.7 Niger Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Niger Pneumococcal Vaccines Market, By Vaccine Technology |
6.2.1 Overview and Analysis |
6.2.2 Niger Pneumococcal Vaccines Market Revenues & Volume, By Protein-based, 2021 - 2031F |
6.2.3 Niger Pneumococcal Vaccines Market Revenues & Volume, By Recombinant, 2021 - 2031F |
6.2.4 Niger Pneumococcal Vaccines Market Revenues & Volume, By Inactivated, 2021 - 2031F |
6.2.5 Niger Pneumococcal Vaccines Market Revenues & Volume, By mRNA-based, 2021 - 2031F |
6.2.6 Niger Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 Niger Pneumococcal Vaccines Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Niger Pneumococcal Vaccines Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Niger Pneumococcal Vaccines Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 Niger Pneumococcal Vaccines Market Revenues & Volume, By Government, 2021 - 2031F |
6.3.5 Niger Pneumococcal Vaccines Market Revenues & Volume, By NGOs, 2021 - 2031F |
6.3.6 Niger Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.4 Niger Pneumococcal Vaccines Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Niger Pneumococcal Vaccines Market Revenues & Volume, By Immunization, 2021 - 2031F |
6.4.3 Niger Pneumococcal Vaccines Market Revenues & Volume, By Disease Prevention, 2021 - 2031F |
6.4.4 Niger Pneumococcal Vaccines Market Revenues & Volume, By Pediatric Vaccination, 2021 - 2031F |
6.4.5 Niger Pneumococcal Vaccines Market Revenues & Volume, By Elderly Care, 2021 - 2031F |
6.4.6 Niger Pneumococcal Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
7 Niger Pneumococcal Vaccines Market Import-Export Trade Statistics |
7.1 Niger Pneumococcal Vaccines Market Export to Major Countries |
7.2 Niger Pneumococcal Vaccines Market Imports from Major Countries |
8 Niger Pneumococcal Vaccines Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage rates for pneumococcal vaccines in Niger |
8.2 Number of government-funded immunization campaigns targeting pneumococcal diseases |
8.3 Reduction in the incidence rate of pneumococcal diseases in Niger due to vaccination efforts |
9 Niger Pneumococcal Vaccines Market - Opportunity Assessment |
9.1 Niger Pneumococcal Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Niger Pneumococcal Vaccines Market Opportunity Assessment, By Vaccine Technology, 2021 & 2031F |
9.3 Niger Pneumococcal Vaccines Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Niger Pneumococcal Vaccines Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Niger Pneumococcal Vaccines Market - Competitive Landscape |
10.1 Niger Pneumococcal Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Niger Pneumococcal Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here